Anderson Daniel Griffith

Director at Sigilon Therapeutics, Inc.

Sold, on record
$2M
Dollars the filings state
Form 4 sales
1
Latest Jun 2, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Sigilon Therapeutics, Inc.Plan not stated
    Jun 2, 2021 2021

    Sold 200,000 shares at $10.00 ($2M)

    Anderson Daniel Griffith, Director

    Sold 9% of holdings ($22.2M position)2M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Anderson Daniel Griffith
Source
Jun 2, 2021Jun 4, 2021Sigilon Therapeutics, Inc.DirectorForm 4 sale200,000$2M9.0%Plan not statedSEC